Treating mild gestational diabetes mellitus: a cost-effectiveness analysis.

[1]  Gordon B. Hazen,et al.  Sensitivity Analysis and the Expected Value of Perfect Information , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[2]  D. Rouse,et al.  Prophylactic cesarean delivery for fetal macrosomia diagnosed by means of ultrasonography--A Faustian bargain? , 1999, American journal of obstetrics and gynecology.

[3]  J. Kitzmiller Cost analysis of diagnosis and treatment of gestational diabetes mellitus. , 2000, Clinical obstetrics and gynecology.

[4]  M. Kuppermann,et al.  Procedure‐Related Miscarriages and Down Syndrome–Affected Births: Implications for Prenatal Testing Based on Women's Preferences , 2000, Obstetrics and gynecology.

[5]  A. Peaceman,et al.  Cost‐Effectiveness of Elective Cesarean Delivery After One Prior Low Transverse Cesarean , 2000, Obstetrics and gynecology.

[6]  L. Marselli,et al.  Universal screening and intensive metabolic management of gestational diabetes: cost-effectiveness in Italy , 2002, Acta Diabetologica.

[7]  B. W. Bost Cesarean delivery on demand: what will it cost? , 2003, American journal of obstetrics and gynecology.

[8]  G. Suresh,et al.  Cost-Effectiveness of Strategies That Are Intended to Prevent Kernicterus in Newborn Infants , 2004, Pediatrics.

[9]  R. Goldberg,et al.  Elective cesarean section to prevent anal incontinence and brachial plexus injuries associated with macrosomia—a decision analysis , 2004, International Urogynecology Journal.

[10]  A. Caughey Cost-Effectiveness Analysis of Prenatal Diagnosis: Methodological Issues and Concerns , 2005, Gynecologic and Obstetric Investigation.

[11]  Caroline A Crowther,et al.  Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. , 2005, The New England journal of medicine.

[12]  C. Phibbs,et al.  Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants. , 2006, Early human development.

[13]  M. Sculpher,et al.  Decision Modelling for Health Economic Evaluation , 2006 .

[14]  A. Washington,et al.  Chilean women’s preferences regarding mode of delivery: which do they prefer and why? , 2006, BJOG : an international journal of obstetrics and gynaecology.

[15]  J. Hiller,et al.  Costs and consequences of treatment for mild gestational diabetes mellitus – evaluation from the ACHOIS randomised trial , 2007, BMC pregnancy and childbirth.

[16]  D. Pettitt,et al.  Screening for Gestational Diabetes Mellitus: A Systematic Review for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[17]  G. Dildy,et al.  Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. , 2008, American journal of obstetrics and gynecology.

[18]  G. ter Riet,et al.  Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. , 2008, Health technology assessment.

[19]  Bengt Persson,et al.  Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .

[20]  Dwight J Rouse,et al.  A multicenter, randomized trial of treatment for mild gestational diabetes. , 2009, The New England journal of medicine.

[21]  A. Lloyd,et al.  Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK , 2009 .

[22]  Jiaquan Xu,et al.  Deaths: final data for 2006. , 2009, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[23]  Yvonne W. Cheng,et al.  Carpenter-Coustan Criteria Compared With the National Diabetes Data Group Thresholds for Gestational Diabetes Mellitus , 2009, Obstetrics and gynecology.

[24]  Yvonne W. Cheng,et al.  The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. , 2009, American journal of obstetrics and gynecology.

[25]  A. Dyer,et al.  The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. , 2010, American journal of obstetrics and gynecology.

[26]  Elisa F. Long,et al.  Cost-effectiveness of elective induction of labor at 41 weeks in nulliparous women. , 2011, American journal of obstetrics and gynecology.